Clinical Pharmacy in 2020: an Alternative Future for Clinical Pharmacy in a Rural Setting

This article describes one of the future possibilities of the clinical pharmacy in 2020, the role of the pharmacist in this scenario, and the procedures necessary to achieve this reality. In particular, it will provide the future of clinical pharmacies in rural areas.

An analysis of new issues of global and national trends promoting change will be used to criticize the present. Furthermore, the causative stratification analysis (CLA) was conducted on problems and problems in rural pharmacy operations. CLA is a tool developed by Futurists to investigate the current problem and the paradigm at several different knowledge levels. CLA is used as a template to provide vision to rural clinical pharmacies. Outline of broad strategy leading to transition from reality to priority

Since the advent of modern clinical pharmacies, implementation of outpatient clinical pharmacies has become a unique pharmaceutical practice environment. Outpatient diagnostic pharmacy is based mainly on drugs provided by pharmacists at clinics. In this case, the pharmacist usually does not distribute medicine, but instead confirm that the patient is managing the chronic illness in the clinic. In the US Federal Health Care System (including VA, Indian Health Service, NIH), outpatient pharmacists have completely independent prescription rights. In some states, such as North Carolina and New Mexico, these pharmacist clinicians are authorized to regulate and diagnose. In 2011, the Council of the pharmacy approved the Outpatient Medicine Pharmacy operation as a separate Council certification.

The vision of the American College of Clinical Pharmacy (ACCP) is that most clinical pharmacy specialists receive experts approved by the Board within 20 to 30 years. This white paper will explain the rationale for this job. 3 And clarified the recommendation for achieving the vision. As a reason for future quality assurance and occupational privilege processes that require board certification most future clinical and resident physician instructors should be given reasons for board certification and discuss obstacles that impede the realization of this vision .

ACCP's vision is that within 20 to 30 years, most clinical pharmacy experts will become experts approved by the board. Council accreditation for medical professionals is an integral part of quality assurance and professional privileges. As explained in the future vision of JCPP pharmacy operations, pharmacy professionals should continue to be clinical pharmacy practitioners if it develops to a truly patient-centered clinical field. The academic community influences the pharmaceutical culture by educating and training future experts. Clinical teachers and mentors become members of the board